Vera Therapeutics VERA
NASDAQ VERA
$35.89 +0.90 (+2.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vera Therapeutics (VERA) Gains from Investment Securities (2022)

Vera Therapeutics' (VERA) quarterly Gains from Investment Securities came in at $127000.0 in Q3 2022, down 9.29% on a QoQ basis from $140000.0 in Q2 2022.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Vera Therapeutics (VERA) Gains from Investment Securities (2022) Analysis & Trends

Vera Therapeutics (VERA) has 1 years of Gains from Investment Securities data on file, last reported at $127000.0 in Q3 2022.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Vera Therapeutics 2.58 Bn 2.58 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 127,000.00
Jun 30, 2022 140,000.00
Mar 31, 2022 12,000.00